24/7 Customer Support

+1 718 473 0872

U.S. Pharmaceutical Business Analysis

  • November 2011
  • 62 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

Refine your search results

Additional Related Reports

Pathology Description in the US

  • Journal of Health Care for the Poor and Underserved, Volume 22, ...
  • November 2014
    8 pages
  • Hiv  

  • United States  

    Asia  

View report >

Drug Industry - Forecast

  • Parmi Les Sujets Sélectionnés Dans Ce Numéro
  • November 2014
    60 pages
  • Drug  

  • Europe  

    United States  

View report >

Pathology Description in the US

  • Childhood Overweight and Obesity: Data Brief
  • November 2014
    22 pages
  • Obesity  

  • United States  

View report >

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women ...

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Herceptin (HER2-Positive Breast Cancer) - Forecast ...

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • September 2014
  • by Global Data

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Perjeta (HER2-Positive Breast Cancer) - Forecast ...

Breast Cancer-api Insights, 2014

November 2014 $ 1 250

Lung Cancer-api Insights, 2014

November 2014 $ 1 250

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.